Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases (Q42702958)
Jump to navigation
Jump to search
scientific article published on 2 February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases |
scientific article published on 2 February 2015 |
Statements
1 reference
Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases (English)
1 reference
1 reference
Georg Jaeschke
1 reference
Sabine Kolczewski
1 reference
Will Spooren
1 reference
Eric Vieira
1 reference
Nadia Bitter-Stoll
1 reference
Patrick Boissin
1 reference
Edilio Borroni
1 reference
Bernd Büttelmann
1 reference
Simona Ceccarelli
1 reference
Nicole Clemann
1 reference
Beatrice David
1 reference
Christoph Funk
1 reference
Wolfgang Guba
1 reference
Anthony Harrison
1 reference
Thomas Hartung
1 reference
Michael Honer
1 reference
Martin Kuratli
1 reference
Urs Niederhauser
1 reference
Axel Pähler
1 reference
Jens-Uwe Peters
1 reference
Ann Petersen
1 reference
Eric Prinssen
1 reference
Antonio Ricci
1 reference
Daniel Rueher
1 reference
Marianne Rueher
1 reference
Manfred Schneider
1 reference
Paul Spurr
1 reference
Theodor Stoll
1 reference
Daniel Tännler
1 reference
Jürgen Wichmann
1 reference
Richard H Porter
1 reference
Joseph G Wettstein
1 reference
Lothar Lindemann
1 reference
2 February 2015
1 reference
1 reference
Identifiers
1 reference